Adrian Burden
Algemeen Directeur bij Singular ID Pte Ltd.
Profiel
Adrian Burden is Chief Executive Officer and Founder of Singular ID Pte Ltd.
and Founder of the OLED Network of Singapore.
Previously, he was Manager of Business Development and Senior Engineering Fellow of IMRE.
Mr. Burden received a Doctorate in Philosophy from the University of Oxford and an MA degree from the University of Cambridge.
Actieve functies van Adrian Burden
| Bedrijven | Functie | Begin |
|---|---|---|
Singular ID Pte Ltd.
 Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Algemeen Directeur | 01-12-2004 |
Eerdere bekende functies van Adrian Burden
| Bedrijven | Functie | Einde |
|---|---|---|
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Corporate Officer/Principal | - |
Opleiding van Adrian Burden
| University of Cambridge | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Singular ID Pte Ltd.
Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Technology Services |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
